Gary Ullery
Internal Medicine · Blackfoot, IDNPI 1164785382
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,879 of the $2,734 with a category attached, or 68.7%. Modernatx, Inc. accounts for 80.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $2,349 and has fallen 98.8% since, to $27 in 2025. Among internal medicine clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $70.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2K
- GSK$64
- Medtronic$55
- Abbott$43
- Novo Nordisk$38
- Biohaven Pharmaceuticals, Inc.$38
- plus $285 from 15 others
Across 94 payments — averaging $17,969 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$839K
- Sanofi Pasteur Inc.$494K
- Eli Lilly$185K
- Merck$168K
- Eli Lilly Export S.A. Puerto Rico Branch$3K
What the payments were for
- Travel & lodging$1,87969%
- Food & beverage$85531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 7 | $2,211 |
| GSK | 4 | $64 |
| Medtronic | 3 | $55 |
| Abbott | 2 | $43 |
| Novo Nordisk | 3 | $38 |
| Biohaven Pharmaceuticals, Inc. | 3 | $38 |
| Lilly USA, LLC | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Merck | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Novartis | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| AstraZeneca | 1 | $15 |
| AbbVie | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
How this compares
$2,734 in reported general payments places this provider in the 90th percentile of 289 internal medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $45,287 |
| EliquisApixaban | 41 | $29,075 |
| VraylarCariprazine Hcl | 13 | $18,909 |
| MounjaroTirzepatide | 16 | $15,887 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $7,135 |
| GemtesaVibegron | 13 | $5,759 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $5,378 |
| Atomoxetine Hcl | 15 | $3,932 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,889 |
| Celecoxib | 54 | $2,540 |
| Apidra SolostarInsulin Glulisine | 14 | $2,350 |
| Testosterone Cypionate | 23 | $2,218 |
| Omeprazole | 110 | $1,548 |
| Buspirone Hcl | 34 | $1,063 |
| Gabapentin | 97 | $1,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $38 | $45,28749 claims |
| PfizerEliquis | $12 | $29,07541 claims |
| AbbVieVraylar | $15 | $18,90913 claims |
| Lilly USA, LLCMounjaro | $30 | $15,88716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 289 internal medicine providers in Idaho.
Other internal medicine in Blackfoot
- Lance WehrleBlackfoot$1K
- Sherwin D'souzaPocatello$543K
- Diana DumitrascuEagle$143K
- Huiling QiBoise$62K
- Aditya SinghPocatello$37K
- Carolyn BridgesBoise$27K
- Susan WachterIdaho Falls$22K
- Ahmed MahmoodIdaho Falls$21K
- Eric BensonPost Falls$19K
- Douglas AndersenPocatello$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.